Skip to main content
VCbacked
Log inGet Started

Sigrid Therapeutics

Stockholm, Sweden

Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.

$4.0M raised
Oct 2023
Venture - Series Unknown
BiotechnologyMedical Device

Top Investors

Almi InvestJoyance PartnersSocial Starts3T InvestIrrus Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sigrid Therapeutics

How much funding has Sigrid Therapeutics raised?
Sigrid Therapeutics has raised $4.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Who are Sigrid Therapeutics's investors?
Sigrid Therapeutics's investors include Almi Invest, Joyance Partners, Social Starts, 3T Invest, Irrus Investments.
Where is Sigrid Therapeutics headquartered?
Sigrid Therapeutics is headquartered in Stockholm, Sweden.
What does Sigrid Therapeutics do?
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
What stage is Sigrid Therapeutics at?
Sigrid Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sigrid Therapeutics — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/sigrid-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Sigrid Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/sigrid-therapeutics
Wikipedia (cite web)
{{cite web |title=Sigrid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sigrid-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong